瑞思邁公司
US ˙ NYSE ˙ US7611521078

SecurityRMD / ResMed Inc.
InstitutionAGF Investments LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
AGF Investments LLC closes position in RMD / ResMed Inc.

On November 10, 2022 - AGF Investments LLC filed a 13F-HR form disclosing ownership of 0 shares of ResMed Inc. (US:RMD) valued at $0 USD as of September 30, 2022. The entity filed a previous 13F-HR on August 12, 2022 disclosing 117 shares of ResMed Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2022-11-10 2022-09-30 13F ResMed COM 761152107 0 -117 -100.00 0 -100.00
2022-08-12 2022-06-30 13F ResMed COM 761152107 117 117 25 0.0023
2022-02-01 2021-12-31 13F ResMed COM 761152107 0 -2,108 -100.00 0 -100.00
2021-11-10 2021-09-30 13F ResMed COM 761152107 2,108 -968 -31.47 556 -26.65 0.0549
2021-08-12 2021-06-30 13F ResMed COM 761152107 3,076 3,076 758 0.0783
2020-11-12 2020-09-30 13F ResMed COM 761152107 0 -164 -100.00 0 -100.00
2020-08-11 2020-06-30 13F ResMed COM 761152107 164 -4,822 -96.71 31 -95.78 0.0031
2020-05-08 2020-03-31 13F ResMed COM 761152107 4,986 -866 -14.80 734 -19.07 0.0951
2020-02-12 2019-12-31 13F ResMed COM 761152107 5,852 2,498 74.48 907 100.22 0.1686
2019-11-12 2019-09-30 13F ResMed COM 761152107 3,354 714 27.05 453 40.68 0.1065
2019-07-30 2019-06-30 13F ResMed COM 761152107 2,640 2,640 -21.29 322 -28.92 0.0672
2019-02-08 2018-12-31 13F ResMed Common Stock 761152107 0 -235 -100.00 0 -100.00
2018-11-09 2018-09-30 13F/A-1 ResMed Common Stock 761152107 235 -108 -31.49 27 -25.00 0.0034
2018-11-07 2018-09-30 13F ResMed Common Stock 761152107 235 -108 27
2018-08-13 2018-06-30 13F ResMed Common Stock 761152107 343 343 45.96 36 33.33 0.0041
2017-05-08 2017-03-31 13F RESMED Common Stock 761152107 0 -710 -100.00 0 -100.00
2017-02-01 2016-12-31 13F RESMED Common Stock 761152107 710 710 44 0.0116
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.